title: Rituximab for the treatment of type II mixed cryoglobulinemia.
authors.forename: Francesco
authors.initials: F
authors.lastname: Zaja
authors.forename: Salvatore
authors.initials: S
authors.lastname: De Vita
authors.forename: Domenico
authors.initials: D
authors.lastname: Russo
authors.forename: Angela
authors.initials: A
authors.lastname: Michelutti
authors.forename: Renato
authors.initials: R
authors.lastname: Fanin
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Ferraccioli
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003449:Cryoglobulinemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006526:Hepatitis C / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012217:Rheumatoid Factor / Q000097:blood; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007075:Immunoglobulin M; D000069283:Rituximab; D012217:Rheumatoid Factor